| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 615088 | 41671 | SUERO FISIOLOGICO VITULIA 0,9% SOLUCION PARA PERFUSION | SUERO FISIOLOGICO VITULIA 0,9% SOLUCION PARA PERFUSION, 10 frascos de 500 ml | 0,9% | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/41671/41671_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/41671/41671_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1965-10-01 | 1 | 1 | 1 | 1965-10-01 | 2002-06-04 | 0 | 2011-09-09 | View Edit Delete | ||||||||||||
| 615187 | 42568 | MANITOL MEIN 10% solución para perfusión | MANITOL MEIN 10% solución para perfusión, 12 frascos de 250 ml | 10% | 69 | 12 | 48 | 12 frascos de 250 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/42568/42568_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/42568/42568_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1966-02-01 | 1 | 1 | 1 | 1966-02-01 | 2001-01-17 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 615237 | 27523 | SUERO GLUCOSALINO VITULIA 3,6 %/0,3 % SOLUCIÓN PARA PERFUSIÓN | SUERO GLUCOSALINO VITULIA 3,6 %/0,3 % SOLUCIÓN PARA PERFUSIÓN, 10 frascos de 500 ml | 3,6% + 0,3% | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/27523/27523_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/27523/27523_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1957-04-01 | 1 | 1 | 1 | 1957-04-01 | 2002-06-10 | 0 | 2011-09-09 | View Edit Delete | ||||||||||||
| 615278 | 24612 | DACORTIN 5 mg COMPRIMIDOS | DACORTIN 5 mg COMPRIMIDOS, 500 comprimidos | 5 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/24612/24612_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/24612/24612_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1955-10-01 | 1 | 1 | 1 | 1955-10-01 | 1967-11-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 615310 | 36225 | FORTECORTIN 4 mg/ml SOLUCION INYECTABLE | FORTECORTIN 4 mg SOLUCION INYECTABLE, 100 ampollas de 1 ml | 4 mg/ml inyectable 1 ml | 1 | 100 | 1 | 100 ampollas de 1 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/36225/36225_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/36225/36225_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1961-06-01 | 1 | 1 | 1 | 1961-06-01 | 1967-11-01 | 1 | 2018-03-28 | View Edit Delete | ||||||||||||
| 615328 | 32224 | FORTECORTIN 1 mg COMPRIMIDOS | FORTECORTIN 1 mg COMPRIMIDOS, 500 comprimidos | 1 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32224/32224_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32224/32224_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1959-07-01 | 1 | 1 | 1 | 1959-07-01 | 1980-12-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 615377 | 64849 | CEFAZOLINA NORMON 1 G POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE INTRAVENOSA EFG. | CEFAZOLINA NORMON 1 G POLVO Y DISOLVENTE PARA SOLUCIÓN INYECTABLE INTRAVENOSA EFG. , 100 viales + 100 ampollas de disolvente | 1.000 mg | 45 | 100 | 34 | 100 viales + 100 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64849/64849_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64849/64849_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2002-06-14 | 1 | 1 | 1 | 2002-06-14 | 2002-06-14 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 615435 | 61718 | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA | CARDYL 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA, 500 comprimidos | 40 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61718/61718_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61718/61718_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 38090 | VIATRIS PHARMACEUTICALS S.L.U. | 2000-11-14 | 1 | 1 | 1 | 2000-11-14 | 2001-03-28 | 1 | 2011-02-11 | View Edit Delete | ||||||||||||
| 615500 | 63788 | DOXAZOSINA NORMON 4 mg COMPRIMIDOS EFG | DOXAZOSINA NORMON 4 mg COMPRIMIDOS EFG, 500 comprimidos | 4 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63788/63788_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63788/63788_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-03-30 | 1 | 1 | 1 | 2001-03-30 | 2001-03-30 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 615518 | 63789 | DOXAZOSINA NORMON 2 mg COMPRIMIDOS EFG | DOXAZOSINA NORMON 2 mg COMPRIMIDOS EFG , 500 comprimidos | 2 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63789/63789_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63789/63789_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-03-30 | 1 | 1 | 1 | 2001-03-30 | 2001-03-30 | 1 | 2011-10-20 | View Edit Delete | ||||||||||||
| 615534 | 64850 | CEFAZOLINA NORMON 2 G POLVO PARA SOLUCIÓN INYECTABLE INTRAVENOSA EFG. | CEFAZOLINA NORMON 2 G POLVO PARA SOLUCIÓN INYECTABLE INTRAVENOSA EFG. , 100 viales | 2.000 mg | 45 | 100 | 34 | 100 viales | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/64850/64850_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/64850/64850_p.pdf | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2002-06-17 | 1 | 1 | 1 | 2002-06-17 | 2002-06-17 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 615567 | 57036 | FORTECORTIN 40 mg/5ml SOLUCIÓN INYECTABLE | FORTECORTIN 40 mg/5ml SOLUCIÓN INYECTABLE , 25 ampollas de 5 ml | 40 mg inyectable 5 ml | 1 | 25 | 1 | 25 ampollas de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/57036/57036_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/57036/57036_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 945 | LABORATORIOS ERN S.A. | 1987-01-01 | 1 | 1 | 1 | 1987-01-01 | 1987-04-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 615609 | 63814 | CEFOXITINA NORMON 1 g polvo y disolvente para solución inyectable y para perfusión EFG | CEFOXITINA NORMON 1 g polvo y disolvente para solución inyectable y para perfusión EFG , 100 viales + 100 ampollas de disolvente | 1.000 mg | 45 | 100 | 34 | 100 viales + 100 ampollas de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63814/63814_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63814/63814_p.pdf | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-04-06 | 1 | 1 | 1 | 2001-04-06 | 2001-04-06 | 0 | 2011-10-20 | View Edit Delete | ||||||||||||
| 615799 | 63599 | ENALAPRIL NORMON 20 mg COMPRIMIDOS EFG | ENALAPRIL NORMON 20 mg COMPRIMIDOS EFG , 500 comprimidos | 20 mg | 5 | 500 | 10 | 500 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63599/63599_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63599/63599_p.pdf | 1 | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 6638 | LABORATORIOS NORMON S.A. | 2001-01-18 | 1 | 1 | 1 | 2001-01-18 | 2001-01-18 | 1 | 2011-10-07 | View Edit Delete | ||||||||||||
| 615914 | 39732 | SCANDINIBSA 30 mg/ml SOLUCION INYECTABLE | SCANDINIBSA 30 mg/ml SOLUCION INYECTABLE, 100 cartuchos de 1,8 ml | 30 mg/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/39732/39732_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/39732/39732_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1964-06-01 | 1 | 1 | 1 | 1964-06-01 | 1979-01-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 615955 | 40858 | XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE | XILONIBSA 20 mg/ml + 0,0125 mg/ml SOLUCION INYECTABLE, 100 cartuchos de 1,8 ml (émbolo plano) | 20 mg/ml + 12,5 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml (émbolo plano) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/40858/40858_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/40858/40858_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1965-05-01 | 1 | 1 | 1 | 1965-05-01 | 1981-04-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 615997 | 56202 | SCANDINIBSA 20 MG/ML + 10 MICROGRAMOS/ML SOLUCIÓN INYECTABLE | SCANDINIBSA 20 MG/ML + 10 MICROGRAMOS/ML SOLUCIÓN INYECTABLE, 100 cartuchos de 1,8 ml | 20 mg/ml + 10 microgramos/ml inyectable 1,8 ml | 12 | 100 | 57 | 100 cartuchos de 1,8 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/56202/56202_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/56202/56202_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 1390 | LABORATORIOS INIBSA S.A. | 1984-06-01 | 1 | 1 | 1 | 1984-06-01 | 1984-06-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 616003 | 32726 | KABIPAC CLORURO DE SODIO 9 MG/ML SOLUCION PARA PERFUSION | KABIPAC CLORURO DE SODIO 9 MG/ML SOLUCION PARA PERFUSION , 10 frascos de 500 ml | 0,9% | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32726/32726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32726/32726_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1959-09-01 | 1 | 1 | 1 | 1959-09-01 | 1976-06-01 | 0 | 2011-02-09 | View Edit Delete | ||||||||||||
| 616029 | 32728 | KABIPAC GLUCOSALINO SOLUCION PARA PERFUSION | KABIPAC GLUCOSALINO SOLUCION PARA PERFUSION, 10 frascos de 500 ml | 3,3% + 0,3% | 6 | 10 | 48 | 10 frascos de 500 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32728/32728_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32728/32728_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1959-09-01 | 1 | 1 | 1 | 1959-09-01 | 1976-06-01 | 0 | 2014-04-17 | View Edit Delete | ||||||||||||
| 616045 | 32726 | KABIPAC CLORURO DE SODIO 9 MG/ML SOLUCION PARA PERFUSION | KABIPAC CLORURO DE SODIO 9 MG/ML SOLUCION PARA PERFUSION , 10 frascos de 1.000 ml | 0,9% | 6 | 10 | 48 | 10 frascos de 1.000 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/32726/32726_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/32726/32726_p.pdf | 1 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 14285 | FRESENIUS KABI ESPAÑA, S.A.U. | 1959-09-01 | 1 | 1 | 1 | 1959-09-01 | 1985-09-01 | 0 | 2011-02-09 | View Edit Delete |
Page 39 of 1036, showing 20 records out of 20704 total, starting on record 761, ending on 780